Cargando…
Nebula/DSCR1 Upregulation Delays Neurodegeneration and Protects against APP-Induced Axonal Transport Defects by Restoring Calcineurin and GSK-3β Signaling
Post-mortem brains from Down syndrome (DS) and Alzheimer's disease (AD) patients show an upregulation of the Down syndrome critical region 1 protein (DSCR1), but its contribution to AD is not known. To gain insights into the role of DSCR1 in AD, we explored the functional interaction between DS...
Autores principales: | Shaw, Jillian L., Chang, Karen T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784514/ https://www.ncbi.nlm.nih.gov/pubmed/24086147 http://dx.doi.org/10.1371/journal.pgen.1003792 |
Ejemplares similares
-
Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1
por: Baek, Kwan-Hyuck, et al.
Publicado: (2009) -
DSCR1 is required for both axonal growth cone extension and steering
por: Wang, Wei, et al.
Publicado: (2016) -
Division of labor in the growth cone by DSCR1
por: Catlett, Timothy S., et al.
Publicado: (2016) -
The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease
por: Lee, Soojin, et al.
Publicado: (2016) -
Disruption of axonal transport in neurodegeneration
por: Berth, Sarah H., et al.
Publicado: (2023)